Eli Lilly’s Venture Arm Spins Out With $200M Fund by The Wall Street Journal
Lilly Ventures, the venture capital arm of Eli Lilly & Co., has spun out from its parent in an effort to compensate its members more like a traditional venture firm.
As part of the spinout, completed May 1, Lilly Ventures secured $200 million from its corporate parent to invest in new companies and to support its existing portfolio.
